Evidence map›Paper›PMID 36865335›Full record

ArticleResearch square2023

Tumor type and cell type-specific gene expression alterations in diverse pediatric central nervous system tumors identified using single nuclei RNA-seq.

Min Kyung Lee, Nasim Azizgolshani, Joshua A Shapiro, Lananh N Nguyen, Fred W Kolling, George J Zanazzi, Hildreth Robert Frost, Brock C Christensen

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Min Kyung LeeDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Nasim AzizgolshaniDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Joshua A ShapiroChildhood Cancer Data Lab, Alex's Lemonade Stand Foundation, Bala Cynwyd, PA, USA.
Lananh N NguyenDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Fred W KollingDartmouth Cancer Center, Lebanon, NH, USA.
George J ZanazziDartmouth Cancer Center, Lebanon, NH, USA.
Hildreth Robert FrostDepartment of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Brock C ChristensenDepartment of Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Dartmouth College · USAlex's Lemonade Stand Foundation · USColumbia University Irving Medical Center · USUniversity of Toronto · CA

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI Chengxiang Qiu · 2019 to 2026
$27.2M
Relation Between In-utero Vitamin D and Immune Function in Early Childhood P20GM104416 · NIGMS · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2013 to 2022
$23.7M
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to ImmunotherapyR01CA253976 · NCI · BROWN UNIVERSITY · PI CHRISTENSEN, BROCK C, KELSEY, KARL TIMOTHY · 2021 to 2025
$3.3M
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomesR01CA216265 · NCI · DARTMOUTH COLLEGE · PI CHRISTENSEN, BROCK CLARKE · 2017 to 2021
$2.9M
Cancer-specific gene set testingR21CA253408 · NCI · DARTMOUTH COLLEGE · PI FROST, HILDRETH · 2020 to 2020
$451k
Acquisition of the NextSeq2000 Sequencing platform to Increase Next Generation Sequencing Throughput While Reducing Costs at DartmouthS10OD030242 · OD · DARTMOUTH COLLEGE · PI KOLLING IV, FRED W · 2021 to 2021
$321k
10X Genomics Chromium Single-cell Sequencing to Expand Research At DartmouthS10OD025235 · OD · DARTMOUTH COLLEGE · PI TOMLINSON, CRAIG R · 2018 to 2018
$125k
NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA216265NCI NIH HHS R01 CA253976NCI NIH HHS R21 CA253408NIGMS NIH HHS P20 GM104416NIGMS NIH HHS P20 GM130454NIH HHS S10 OD025235NIH HHS S10 OD030242Wellcome Trust
6 · The paper itself

Abstract

Central nervous system (CNS) tumors are the leading cause of pediatric cancer death, and these patients have an increased risk for developing secondary neoplasms. Due to the low prevalence of pediatric CNS tumors, major advances in targeted therapies have been lagging compared to other adult tumors. We collected single nuclei RNA-seq data from 35 pediatric CNS tumors and three non-tumoral pediatric brain tissues (84,700 nuclei) and characterized tumor heterogeneity and transcriptomic alterations. We distinguished cell subpopulations associated with specific tumor types including radial glial cells in ependymomas and oligodendrocyte precursor cells in astrocytomas. In tumors, we observed pathways important in neural stem cell-like populations, a cell type previously associated with therapy resistance. Lastly, we identified transcriptomic alterations among pediatric CNS tumor types compared to non-tumor tissues, while accounting for cell type effects on gene expression. Our results suggest potential tumor type and cell type-specific targets for pediatric CNS tumor treatment. In this study, we address current gaps in understanding single nuclei gene expression profiles of previously uninvestigated tumor types and enhance current knowledge of gene expression profiles of single cells of various pediatric CNS tumors.

Identifiers

PMID36865335
PMCPMC9980204
OpenAlexW4321606079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.